Nitric oxide helps patients with SARS
Key points
- For patients with severe acute respiratory syndrome (SARS), inhaling nitric oxide leads to improved oxygenation and less need for mechanical ventilation, according to a new report.
- Nitric oxide or NO (not to be confused with nitrous oxide "laughing gas, NO2) has dilating properties, and is sometimes used to help babies with breathing problems, for example.
- Goran Hedenstierna, at Uppsala University in Sweden, and associates in China studied 14 patients with SARS treated in hospitals in Beijing in 2003.
- All the patients were also treated with inhaled oxygen, an antiviral drug and steroids, along with antibiotic or antifungal drugs as needed.
For patients with severe acute respiratory syndrome (SARS), inhaling nitric oxide leads to improved oxygenation and less need for mechanical ventilation, according to a new report.
Nitric oxide or NO (not to be confused with nitrous oxide "laughing gas, NO2) has dilating properties, and is sometimes used to help babies with breathing problems, for example.
Dr. Goran Hedenstierna, at Uppsala University in Sweden, and associates in China studied 14 patients with SARS treated in hospitals in Beijing in 2003. Six were treated with NO and the remaining eight served as "controls."
All the patients were also treated with inhaled oxygen, an antiviral drug and steroids, along with antibiotic or antifungal drugs as needed.
During NO treatment, the amount of oxygen the patients needed was reduced by two-thirds, while the level of oxygen in the blood increased, the team reports in the medical journal Clinical Infectious Diseases.
Only in the NO group was ventilation support reduced during the 10-day study period and then discontinued, with no decrease in blood oxygen saturation.
Chest X-rays showed lung improvements in five of the patients given nitric oxide.
One patient in the NO group and two in the control group died. For the remaining patients, discharge from the hospital took place after an average of 4.4 weeks in the NO group and 6.2 weeks in the control group.
The improvements seen with nitric oxide "can hardly be explained" just by the dilating properties of the gas, Hedenstierna's team believes. They therefore suggest that the treatment had an effect on the disease itself, perhaps by directly inhibiting the SARS virus.
SOURCE: Clinical Infectious Diseases, November 15, 2004.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Infections, HIV & STIs →
NewsHepatitis C treatment cures over 90 percent of patients with cirrhosis
Twelve weeks of an investigational oral therapy cured hepatitis C infection in more than 90 percent of patients with liver cirrhosis and was well tolerated by these patients, according to an international study that…
14 April 2014
NewsNew York hospital warns patients of possible HIV, hepatitis exposure
A New York hospital on Wednesday alerted more than 4,200 patients who may have received insulin of possible exposure to hepatitis viruses and human immunodeficiency virus (HIV) due to possible blood contamination,…
13 March 2014
NewsU of M researchers find HIV protein may impact neurocognitive impairment in infected patients
A protein shed by HIV-infected brain cells alters synaptic connections between networks of nerve cells, according to new research out of the University of Minnesota. The findings could explain why nearly half of all…
